Deciphera Pharmaceuticals, Inc. (DCPH) Social Stream

Deciphera Pharmaceuticals, Inc. (DCPH)

Today's Latest Price: $55.18 USD

1.62 (-2.85%)

Updated Jul 9 12:50pm

Add DCPH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About DCPH

$LVGO $IGMS $DCPH $BRK.A phase 1 data results July 15 $90 could be happen where Will Novavax $NVAX Be in 5 Years? $300 buyout from big pharmaceutical

https://www.fool.com/investing/2020/06/18/where-will-novavax-be-in-5-years.aspx

Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group video

https://www.foxbusiness.com/markets/coronavirus-vaccine-trial-novavax-bill-gates

Novavax’s acquisition of Praha Vaccines along with other associated assets for $167 million in May 2020 new vaccine manufacturing facility located in Bohumil, Czech Republic will develop and manufacture the company’s vaccine candidate for Covid-19, NVX‑CoV2373

https://www.pharmaceutical-technology.com/projects/novavax-covid-19-vaccine-manufacturing-facility/

David Mott seems has a notoriety for doing one thing in particular: handling sales and acquisitions of companies. He has served on 25 different boards. He will not be with Novavax for an extended period of time. He showed up to help sell Novavax $NVAX to Big Pharma.

https://www.forbes.com/profile/david-mott/#33363b008c00
vaccinetreatment2020, published July 7, 2020

Loading social stream, please wait...



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4909 seconds.